Q1 2011

Filed May 6, 2011 · 10-Q · 36 days after period end · 0001054102-11-000036

Q1 2011 · 10-Q

Revenue

$44.30M

no prior Q1 2010 on file

Net Income

-$550.00K

no prior Q1 2010 on file

EPS Diluted

-$0.04

no prior Q1 2010 on file

Gross Profit$8,163,000—

Operating Income

Same quarter

no prior Q1 2010 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

ended Mar 31, 2011 · filed May 6, 2011 · 36 d after period end

Interpace Biosciences, Inc. · CIK 1054102 · Engraved from SEC EDGAR